Commonwealth of Pennsylvania Public School Employees Retirement System’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.5M | Sell |
4,752
-115
| -2% | -$27.1K | 0.01% | 983 |
|
|
2026
Q1 | $972K | Sell |
4,867
-6
| -0.1% | -$1.19K | 0.01% | 1132 |
|
|
2025
Q4 | $921K | Sell |
4,873
-118
| -2% | -$22.7K | ﹤0.01% | 1149 |
|
|
2025
Q3 | $884K | Buy |
4,991
+37
| +0.7% | +$5.5K | ﹤0.01% | 1160 |
|
|
2025
Q2 | $563K | Buy |
4,954
+432
| +10% | +$46.2K | ﹤0.01% | 1284 |
|
|
2025
Q1 | $475K | Buy |
4,522
+488
| +12% | +$55.2K | ﹤0.01% | 1317 |
|
|
2024
Q4 | $432K | Buy |
4,034
+129
| +3% | +$14.6K | ﹤0.01% | 1333 |
|
|
2024
Q3 | $391K | Buy |
3,905
+266
| +7% | +$26.8K | ﹤0.01% | 1342 |
|
|
2024
Q2 | $307K | Buy |
3,639
+100
| +3% | +$7.96K | ﹤0.01% | 1375 |
|
|
2024
Q1 | $259K | Buy |
3,539
+2
| +0.1% | +$147 | ﹤0.01% | 1414 |
|
|
2023
Q4 | $253K | Sell |
3,537
-7,370
| -68% | -$435K | ﹤0.01% | 1408 |
|
|
2023
Q3 | $654K | Sell |
10,907
-7,642
| -41% | -$503K | 0.01% | 1325 |
|
|
2023
Q2 | $1.34M | Buy |
18,549
+1,556
| +9% | +$117K | 0.01% | 1270 |
|
|
2023
Q1 | $1.25M | Sell |
16,993
-183
| -1% | -$13K | 0.01% | 1213 |
|
|
2022
Q4 | $1.15M | Sell |
17,176
-6,249
| -27% | -$406K | 0.01% | 1258 |
|
|
2022
Q3 | $1.26M | Sell |
23,425
-1,213
| -5% | -$71.3K | 0.01% | 1037 |
|
|
2022
Q2 | $1.37M | Buy |
24,638
+1,544
| +7% | +$87.6K | 0.01% | 1031 |
|
|
2022
Q1 | $1.62M | Buy |
23,094
+2,847
| +14% | +$207K | 0.02% | 1000 |
|
|
2021
Q4 | $1.95M | Sell |
20,247
-23
| -0.1% | -$2.13K | 0.02% | 827 |
|
|
2021
Q3 | $1.76M | Buy |
20,270
+11,378
| +128% | +$880K | 0.02% | 852 |
|
|
2021
Q2 | $728K | Buy |
8,892
+8
| +0.1% | +$665 | 0.01% | 1419 |
|
|
2021
Q1 | $845K | Buy |
8,884
+276
| +3% | +$26.1K | 0.01% | 1362 |
|
|
2020
Q4 | $534K | Buy |
8,608
+348
| +4% | +$19.8K | 0.01% | 1452 |
|
|
2020
Q3 | $491K | Buy |
8,260
+2,816
| +52% | +$192K | 0.01% | 1358 |
|
|
2020
Q2 | $380K | Sell |
5,444
-780
| -13% | -$49.4K | 0.01% | 1275 |
|
|
2020
Q1 | $282K | Buy |
6,224
+1,258
| +25% | +$71.3K | 0.01% | 1293 |
|
|
2019
Q4 | $323K | Sell |
4,966
-399
| -7% | -$26.7K | 0.01% | 1328 |
|
|
2019
Q3 | $333K | Sell |
5,365
-172
| -3% | -$10.8K | 0.01% | 1266 |
|
|
2019
Q2 | $394K | Sell |
5,537
-237
| -4% | -$17.5K | 0.01% | 1178 |
|
|
2019
Q1 | $453K | Sell |
5,774
-205
| -3% | -$15.5K | 0.01% | 1115 |
|
|
2018
Q4 | $506K | Sell |
5,979
-2,097
| -26% | -$224K | 0.01% | 952 |
|
|
2018
Q3 | $1.38M | Buy |
8,076
+846
| +12% | +$128K | 0.02% | 496 |
|
|
2018
Q2 | $934K | Buy |
7,230
+4,066
| +129% | +$454K | 0.01% | 840 |
|
|
2018
Q1 | $326K | Buy |
+3,164
| New | +$313K | ﹤0.01% | 1095 |
|
|
2014
Q3 | – | Sell |
-16,030
| Closed | -$623K | – | 1267 |
|
|
2014
Q2 | $623K | Buy |
16,030
+176
| +1% | +$7.14K | 0.01% | 1048 |
|
|
2014
Q1 | $665K | Buy |
15,854
+6,140
| +63% | +$256K | 0.01% | 997 |
|
|
2013
Q4 | $319K | Buy |
+9,714
| New | +$317K | 0.01% | 1235 |
|
Other funds holding LGND
JT
CAM
Commonwealth of Pennsylvania Public School Employees Retirement System's LGND Position: Q2 2026 in Review
Commonwealth of Pennsylvania Public School Employees Retirement System reduced its Ligand Pharmaceuticals (LGND) stake by 2.4% in Q2 2026, selling an estimated $27.1K and leaving 4,752 shares worth $1.5M. The position accounts for 0.01% of the portfolio, ranked #983.
Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in LGND in Q4 2013 and has held it in 37 quarters since. The position peaked at $1.95M in Q4 2021. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Commonwealth of Pennsylvania Public School Employees Retirement System held 4,752 shares of Ligand Pharmaceuticals worth $1.5M as of Q2 2026.
- Commonwealth of Pennsylvania Public School Employees Retirement System sold 115 Ligand Pharmaceuticals shares in Q2 2026, an estimated $27.1K.
- Ligand Pharmaceuticals made up 0.01% of Commonwealth of Pennsylvania Public School Employees Retirement System's portfolio in Q2 2026, its #983 holding.
- Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in Ligand Pharmaceuticals in Q4 2013 and has held it in 37 quarters since.
- Commonwealth of Pennsylvania Public School Employees Retirement System's Ligand Pharmaceuticals position peaked at $1.95M in Q4 2021.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q2 2026, filed 17 Jul 2026.